Establishing Rationale for the Clinical Development of Cell Therapy Products: Consensus between Risk and Benefit

Despite long-term research achievements, the development of cell therapy (CT) products remains challenging. This is because the risks experienced by the subject and therapeutic effects in the clinical trial stage are unclear due to the various uncertainties of CT when administered to humans. Neverth...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Seunghoon, Yim, Hyeon Woo, Jeong, Hyunsuk, Choi, Suein, Han, Sungpil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978837/
https://www.ncbi.nlm.nih.gov/pubmed/36581365
http://dx.doi.org/10.15283/ijsc21189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978837/
https://www.ncbi.nlm.nih.gov/pubmed/36581365
http://dx.doi.org/10.15283/ijsc21189

Ejemplares similares